Institutional Ownership Travere Therapeutics, Inc. (TVTX)
This table provides information about the institutional ownership of Travere Therapeutics, Inc. (TVTX). We have compiled data on the 230 institutions that hold shares in the stock, with a total of 102 Million shares, which have been reported (via 13F filing form) to have a value of $2.43 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
9,541,270
shares
|
$231 Million
0.07% of portfolio
|
Q2 2025
Added 26.73%
|
|
|
Armistice Capital, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
8,876,000
shares
|
$215 Million
2.3% of portfolio
|
Q2 2025
Added 0.05%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
7,644,789
shares
|
$185 Million
0.0% of portfolio
|
Q2 2024
Reduced 1.95%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
5,994,283
shares
|
$145 Million
0.0% of portfolio
|
Q2 2025
Added 19.55%
|
|
|
Macquarie Group LTD
Australia, C3 |
Aug 14, 2025 Q2 2025 |
5,097,482
shares
|
$123 Million
0.1% of portfolio
|
Q2 2025
Added 6.26%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
3,483,176
shares
|
$84.4 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.48%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,784,000
shares
|
$67.4 Million
0.07% of portfolio
|
Q2 2025
Added 27.42%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
2,495,114
shares
|
$60.4 Million
0.05% of portfolio
|
Q2 2025
Reduced 7.68%
|
|
|
Emerald Advisers, LLC
|
Aug 04, 2025 Q2 2025 |
2,091,360
shares
|
$50.7 Million
1.22% of portfolio
|
Q2 2025
Added 0.68%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
2,003,701
shares
|
$48.5 Million
0.0% of portfolio
|
Q2 2025
Added 1.37%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,957,120
shares
|
$47.4 Million
0.04% of portfolio
|
Q2 2023
Added 26.22%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
1,908,208
shares
|
$46.2 Million
1.92% of portfolio
|
Q2 2025
Reduced 34.68%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,743,190
shares
|
$42.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.85%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2025 Q2 2025 |
1,621,393
shares
|
$39.3 Million
0.0% of portfolio
|
Q2 2025
Added 71.41%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
1,568,544
shares
|
$38 Million
0.0% of portfolio
|
Q2 2025
Reduced 4.48%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
1,556,852
shares
|
$37.7 Million
0.0% of portfolio
|
Q2 2025
Added 79.43%
|
|
|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
1,540,691
shares
|
$37.3 Million
2.72% of portfolio
|
Q2 2025
Reduced 14.54%
|
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,315,033
shares
|
$31.9 Million
1.96% of portfolio
|
Q2 2025
Added 61.11%
|
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
1,194,335
shares
|
$28.9 Million
0.01% of portfolio
|
Q2 2025
Reduced 0.77%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,150,000
shares
|
$27.9 Million
0.37% of portfolio
|
Q4 2024
New holding
|
|
|
Emerald Mutual Fund Advisers Trust
|
Aug 04, 2025 Q2 2025 |
1,141,428
shares
|
$27.6 Million
1.15% of portfolio
|
Q2 2025
Added 1.74%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
1,130,750
shares
|
$27.4 Million
0.01% of portfolio
|
Q2 2025
Reduced 34.01%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
1,103,075
shares
|
$26.7 Million
0.03% of portfolio
|
Q2 2025
Added 166.76%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
1,057,700
shares
|
$25.6 Million
0.03% of portfolio
|
Q2 2025
Added 1.15%
|
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
1,002,092
shares
|
$24.3 Million
0.78% of portfolio
|
Q2 2025
New holding
|